| Year |
Citation |
Score |
| 2022 |
Pennell CA, Campbell H, Storlie MD, Bolivar-Wagers S, Osborn MJ, Refaeli Y, Jensen M, Viaud S, Young TS, Blazar BR. Human CD19-specific switchable CAR T-cells are efficacious as constitutively active CAR T-cells but cause less morbidity in a mouse model of human CD19 malignancy. Journal For Immunotherapy of Cancer. 10. PMID 36521930 DOI: 10.1136/jitc-2022-005934 |
0.502 |
|
| 2020 |
Thangavelu G, Wang C, Loschi M, Saha A, Osborn M, Furlan SN, Aoyama K, McDonald-Hyman C, Aguilar EG, Janesick AS, Chandraratna RA, Refaeli Y, Panoskaltsis-Mortari A, MacDonald KP, Hill GR, et al. Repurposing a novel anti-cancer RXR agonist to attenuate acute GVHD and maintain graft-versus-leukemia responses. Blood. PMID 32976550 DOI: 10.1182/blood.2020005628 |
0.395 |
|
| 2019 |
Saha A, Taylor PA, Lees CJ, Panoskaltsis-Mortari A, Osborn MJ, Feser CJ, Thangavelu G, Melchinger W, Refaeli Y, Hill GR, Munn DH, Murphy WJ, Serody JS, Maillard I, Kreymborg K, et al. Donor and host B7-H4 expression negatively regulates acute graft-versus-host disease lethality. Jci Insight. 4. PMID 31578305 DOI: 10.1172/Jci.Insight.127716 |
0.427 |
|
| 2018 |
Pennell CA, Barnum JL, McDonald-Hyman CS, Panoskaltsis-Mortari A, Riddle MJ, Xiong Z, Loschi M, Thangavelu G, Campbell HM, Storlie MD, Refaeli Y, Furlan SN, Jensen MC, Kean LS, Miller JS, et al. Human CD19-Targeted Mouse T Cells Induce B Cell Aplasia and Toxicity in Human CD19 Transgenic Mice. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 29735365 DOI: 10.1016/J.Ymthe.2018.04.006 |
0.573 |
|
| 2017 |
Jacobs L, Habringer S, Slawska J, Huber K, Hauf E, Li Z, Refaeli Y, Schwaiger M, Rudelius M, Walch A, Keller U. Functional imaging in combination with mutation status aids prediction of response to inhibiting B-cell receptor signaling in lymphoma. Oncotarget. 8: 78917-78929. PMID 29108275 DOI: 10.18632/Oncotarget.20551 |
0.358 |
|
| 2016 |
Morton JJ, Bird G, Refaeli Y, Jimeno A. Humanized mouse xenograft models: narrowing the tumor-microenvironment gap. Cancer Research. PMID 27587540 DOI: 10.1158/0008-5472.Can-16-1260 |
0.365 |
|
| 2015 |
Morton JJ, Bird G, Keysar SB, Astling DP, Lyons TR, Anderson RT, Glogowska MJ, Estes P, Eagles JR, Le PN, Gan G, McGettigan B, Fernandez P, Padilla-Just N, Varella-Garcia M, ... ... Refaeli Y, et al. XactMice: humanizing mouse bone marrow enables microenvironment reconstitution in a patient-derived xenograft model of head and neck cancer. Oncogene. PMID 25893296 DOI: 10.1038/Onc.2015.94 |
0.458 |
|
| 2014 |
Bird GA, Polsky A, Estes P, Hanlon T, Hamilton H, Morton JJ, Gutman J, Jimeno A, Turner BC, Refaeli Y. Expansion of human and murine hematopoietic stem and progenitor cells ex vivo without genetic modification using MYC and Bcl-2 fusion proteins. Plos One. 9: e105525. PMID 25170611 DOI: 10.1371/Journal.Pone.0105525 |
0.386 |
|
| 2012 |
Bjordahl RL, Gapin L, Marrack P, Refaeli Y. iNKT cells suppress the CD8+ T cell response to a murine Burkitt's-like B cell lymphoma. Plos One. 7: e42635. PMID 22880059 DOI: 10.1371/Journal.Pone.0042635 |
0.608 |
|
| 2012 |
Refaeli Y, Van Parijs L, Alexander SI, Abbas AK. Interferon γ is required for activation-induced death of T lymphocytes The Journal of Experimental Medicine. 209: 1049-1049. DOI: 10.1084/Jem.200206662095C |
0.459 |
|
| 2009 |
Young RM, Polsky A, Refaeli Y. TC-PTP is required for the maintenance of MYC-driven B-cell lymphomas. Blood. 114: 5016-23. PMID 19755676 DOI: 10.1182/Blood-2008-12-196709 |
0.547 |
|
| 2009 |
Refaeli Y, Bhoumik A, Roop DR, Ronai ZA. Melanoma-initiating cells: a compass needed. Embo Reports. 10: 965-72. PMID 19680286 DOI: 10.1038/Embor.2009.184 |
0.404 |
|
| 2009 |
Clarke RL, Thiemann S, Refaeli Y, Werlen G, Potter TA. A new function for LAT and CD8 during CD8-mediated apoptosis that is independent of TCR signal transduction. European Journal of Immunology. 39: 1619-31. PMID 19449311 DOI: 10.1002/Eji.200839062 |
0.353 |
|
| 2009 |
Van Parijs L, Refaeli Y, Lord JD, Nelson BH, Abbas AK, Baltimore D. Retraction. Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death. Immunity. 30: 611. PMID 19382300 DOI: 10.1016/j.immuni.2009.04.002 |
0.352 |
|
| 2009 |
Van Parijs L, Refaeli Y, Abbas AK, Baltimore D. Retraction. Autoimmunity as a consequence of retrovirus-mediated expression of C-FLIP in lymphocytes. Immunity. 30: 612. PMID 19378495 DOI: 10.1016/J.Immuni.2009.04.003 |
0.411 |
|
| 2009 |
Zemans RL, Briones N, Young SK, Malcolm KC, Refaeli Y, Downey GP, Worthen GS. A novel method for long term bone marrow culture and genetic modification of murine neutrophils via retroviral transduction. Journal of Immunological Methods. 340: 102-15. PMID 19010330 DOI: 10.1016/J.Jim.2008.10.004 |
0.328 |
|
| 2009 |
Young RM, Hardy IR, Clarke RL, Lundy N, Pine P, Turner BC, Potter TA, Refaeli Y. Mouse models of non-Hodgkin lymphoma reveal Syk as an important therapeutic target. Blood. 113: 2508-16. PMID 18981293 DOI: 10.1182/Blood-2008-05-158618 |
0.498 |
|
| 2008 |
Young RM, Turner BC, Refaeli Y. B-cell receptor signaling in the genesis and maintenance of B-cell lymphoma. Future Oncology (London, England). 4: 591-4. PMID 18922114 DOI: 10.2217/14796694.4.5.591 |
0.545 |
|
| 2008 |
Refaeli Y, Young RM, Turner BC, Duda J, Field KA, Bishop JM. The B cell antigen receptor and overexpression of MYC can cooperate in the genesis of B cell lymphomas. Plos Biology. 6: e152. PMID 18578569 DOI: 10.1371/Journal.Pbio.0060152 |
0.505 |
|
| 2008 |
Field KA, Charoenthongtrakul S, Bishop JM, Refaeli Y. Farnesyl transferase inhibitors induce extended remissions in transgenic mice with mature B cell lymphomas. Molecular Cancer. 7: 39. PMID 18489761 DOI: 10.1186/1476-4598-7-39 |
0.517 |
|
| 2008 |
Jin L, Stolpa JC, Young RM, Pugh-Bernard AE, Refaeli Y, Cambier JC. MHC class II structural requirements for the association with Igalpha/beta, and signaling of calcium mobilization and cell death. Immunology Letters. 116: 184-94. PMID 18194817 DOI: 10.1016/J.Imlet.2007.11.023 |
0.363 |
|
| 2008 |
Turner BC, Eves T, Refaeli Y. Small-molecule inhibitors of Bcl-2 family proteins are able to induce tumor regression in a mouse model of pre-B-cell acute lymphocytic lymphoma. Dna and Cell Biology. 27: 133-42. PMID 18163880 DOI: 10.1089/Dna.2007.0675 |
0.545 |
|
| 2007 |
Chu HW, Thaikoottathil J, Rino JG, Zhang G, Wu Q, Moss T, Refaeli Y, Bowler R, Wenzel SE, Chen Z, Zdunek J, Breed R, Young R, Allaire E, Martin RJ. Function and regulation of SPLUNC1 protein in Mycoplasma infection and allergic inflammation. Journal of Immunology (Baltimore, Md. : 1950). 179: 3995-4002. PMID 17785838 DOI: 10.4049/Jimmunol.179.6.3995 |
0.331 |
|
| 2007 |
Jorgensen TN, McKee A, Wang M, Kushnir E, White J, Refaeli Y, Kappler JW, Marrack P. Bim and Bcl-2 mutually affect the expression of the other in T cells. Journal of Immunology (Baltimore, Md. : 1950). 179: 3417-24. PMID 17785775 DOI: 10.4049/Jimmunol.179.6.3417 |
0.398 |
|
| 2005 |
Refaeli Y, Field KA, Turner BC, Trumpp A, Bishop JM. The protooncogene MYC can break B cell tolerance. Proceedings of the National Academy of Sciences of the United States of America. 102: 4097-102. PMID 15753301 DOI: 10.1073/Pnas.0409832102 |
0.548 |
|
| 2002 |
Refaeli Y, Van Parijs L, Alexander SI, Abbas AK. Interferon gamma is required for activation-induced death of T lymphocytes. The Journal of Experimental Medicine. 196: 999-1005. PMID 12370261 DOI: 10.1084/jem.20020666 |
0.354 |
|
| 2002 |
Kelly E, Won A, Refaeli Y, Van Parijs L. IL-2 and related cytokines can promote T cell survival by activating AKT. Journal of Immunology (Baltimore, Md. : 1950). 168: 597-603. PMID 11777951 DOI: 10.4049/Jimmunol.168.2.597 |
0.437 |
|
| 2001 |
Trumpp A, Refaeli Y, Oskarsson T, Gasser S, Murphy M, Martin GR, Bishop JM. c-Myc regulates mammalian body size by controlling cell number but not cell size. Nature. 414: 768-73. PMID 11742404 DOI: 10.1038/414768A |
0.355 |
|
| 2001 |
Lois C, Refaeli Y, Qin XF, Van Parijs L. Retroviruses as tools to study the immune system. Current Opinion in Immunology. 13: 496-504. PMID 11498308 DOI: 10.1016/S0952-7915(00)00247-8 |
0.306 |
|
| 2000 |
Buchholz F, Refaeli Y, Trumpp A, Bishop JM. Inducible chromosomal translocation of AML1 and ETO genes through Cre/loxP-mediated recombination in the mouse. Embo Reports. 1: 133-9. PMID 11265752 DOI: 10.1093/Embo-Reports/Kvd027 |
0.385 |
|
| 2000 |
Dickey C, Ziegner U, Agadjanyan MG, Srikantan V, Refaeli Y, Prabhu A, Sato A, Williams WV, Weiner DB, Ugen KE. Murine monoclonal antibodies biologically active against the amino region of HIV-1 gp120: isolation and characterization. Dna and Cell Biology. 19: 243-52. PMID 10798448 DOI: 10.1089/104454900314519 |
0.305 |
|
| 1999 |
Van Parijs L, Refaeli Y, Abbas AK, Baltimore D. Autoimmunity as a consequence of retrovirus-mediated expression of C-FLIP in lymphocytes. Immunity. 11: 763-70. PMID 10626898 DOI: 10.1016/S1074-7613(00)80150-8 |
0.468 |
|
| 1999 |
Van Parijs L, Refaeli Y, Lord JD, Nelson BH, Abbas AK, Baltimore D. Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death. Immunity. 11: 281-8. PMID 10514006 DOI: 10.1016/S1074-7613(00)80103-X |
0.423 |
|
| 1999 |
Refaeli Y, Van Parijs L, Abbas AK. Genetic models of abnormal apoptosis in lymphocytes. Immunological Reviews. 169: 273-82. PMID 10450524 DOI: 10.1111/J.1600-065X.1999.Tb01322.X |
0.39 |
|
| 1998 |
Refaeli Y, Van Parijs L, London CA, Tschopp J, Abbas AK. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity. 8: 615-23. PMID 9620682 DOI: 10.1016/S1074-7613(00)80566-X |
0.431 |
|
| 1995 |
Levy DN, Refaeli Y, Weiner DB. Extracellular Vpr protein increases cellular permissiveness to human immunodeficiency virus replication and reactivates virus from latency. Journal of Virology. 69: 1243-52. PMID 7815499 DOI: 10.1128/Jvi.69.2.1243-1252.1995 |
0.378 |
|
| 1995 |
Levy DN, Refaeli Y, Weiner DB. The vpr regulatory gene of HIV. Current Topics in Microbiology and Immunology. 193: 209-36. PMID 7648876 DOI: 10.1007/978-3-642-78929-8_11 |
0.315 |
|
| 1994 |
Levy DN, Refaeli Y, MacGregor RR, Weiner DB. Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1. Proceedings of the National Academy of Sciences of the United States of America. 91: 10873-7. PMID 7971975 DOI: 10.1073/Pnas.91.23.10873 |
0.381 |
|
| 1993 |
Wang B, Ugen KE, Srikantan V, Agadjanyan MG, Dang K, Refaeli Y, Sato AI, Boyer J, Williams WV, Weiner DB. Gene inoculation generates immune responses against human immunodeficiency virus type 1 Proceedings of the National Academy of Sciences of the United States of America. 90: 4156-4160. PMID 8483929 DOI: 10.1073/Pnas.90.9.4156 |
0.333 |
|
| Show low-probability matches. |